There are a lot of ompanies in this game, but the biggest ones that we're focusing on right now are bristol, myr squib, johnson johnson. And then bar which is, of course, the german company behind aspiran. There's another company called anthos, and they are spi out from novardis,. They are using diologic drunk, so it would be infused or injected. Some of these names, adelca, are already bringing in some money for these big farmer names, aren't they yet? Eloquis and zaralto will lose their patent exclusivity on within the next few years.
Bloomberg News West Coast Correspondent Ed Ludlow reports on Apple backing off plans to increase production of its new iPhones this year after an anticipated surge in demand failed to materialize. Bloomberg News Finance Reporter Hannah Levitt discusses how a US investigation into unauthorized texting on Wall Street is forcing many of the world’s biggest banks to create a new compliance role: the WhatsApp cop. Bloomberg News Health Care Reporter Angelica Peebles shares the details of her Businessweek Magazine story Big Pharma Chases $55 Billion Prize of Safer Blood Thinners. And we Drive to the Close with Doug Ciocca, CEO at Kavar Capital. Hosts: Carol Massar and Scarlet Fu. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.